Intelligent Bio Solutions (INBS) Equity Average (2021 - 2024)
Historic Equity Average for Intelligent Bio Solutions (INBS) over the last 4 years, with Q1 2024 value amounting to $7.2 million.
- Intelligent Bio Solutions' Equity Average fell 1151.89% to $7.2 million in Q1 2024 from the same period last year, while for Mar 2024 it was $7.2 million, marking a year-over-year decrease of 1151.89%. This contributed to the annual value of $5.2 million for FY2023, which is 5192.54% down from last year.
- Intelligent Bio Solutions' Equity Average amounted to $7.2 million in Q1 2024, which was down 1151.89% from $2.3 million recorded in Q4 2023.
- In the past 5 years, Intelligent Bio Solutions' Equity Average registered a high of $15.5 million during Q2 2021, and its lowest value of $2.3 million during Q4 2023.
- In the last 4 years, Intelligent Bio Solutions' Equity Average had a median value of $7.5 million in 2022 and averaged $7.8 million.
- In the last 5 years, Intelligent Bio Solutions' Equity Average tumbled by 5031.01% in 2022 and then crashed by 1151.89% in 2024.
- Quarter analysis of 4 years shows Intelligent Bio Solutions' Equity Average stood at $14.3 million in 2021, then plummeted by 46.19% to $7.7 million in 2022, then plummeted by 69.89% to $2.3 million in 2023, then surged by 210.9% to $7.2 million in 2024.
- Its last three reported values are $7.2 million in Q1 2024, $2.3 million for Q4 2023, and $2.6 million during Q3 2023.